Classico Inc.

Classico Inc.

442A.T
Classico Inc.JP flagTokyo Stock Exchange
962.00
JPY
-13.00
- -
1.99BMarket Cap
Classico Inc.
442A.T
(Tokyo Stock Exchange)

Recent

price

962.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
FRC
- -
1,790.54
Revenue per Share
- -
83.76
Basic EPS, GAAP
- -
-74.68
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
- -
697.01
Book Value per Share
- -
694.21
Tangible Book Value per Share
1
2
Basic Weighted Avg Shares
- -
3,632
Sales/Revenue/Turnover
- -
4.54
Operating Margin (%)
- -
7
Depreciation Expense
- -
170
Net Income, GAAP
- -
- -
Effective Tax Rate (%)
- -
4.68
Profit Margin (%)
- -
1,456
Working Capital
- -
268
LT Debt
- -
1,414
Total Equity
- -
- -
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
24.03
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
3,632
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
83.76
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Classico Inc. manufactures and provides testing, automation, and analytical equipment and related services for the chemical, pharmaceutical, and semiconductor industries; company offerings span laboratory and process instrumentation, high-precision measurement devices, turnkey analytical systems, custom automation solutions, software for data acquisition and control, after-sales support, and training services. Headquartered in Tokyo, Japan, Classico operates globally with manufacturing, sales, and service presence in Asia-Pacific, Europe, and North America. Founded in 1990, the company focuses on delivering integrated solutions that enable product characterization, quality control, process optimization, and compliance for customers across research, development, and manufacturing environments. Main products and services: core product categories include analytical instruments (spectroscopy, chromatography, mass spectrometry interfaces, and sensor platforms), process control and automation systems (control hardware, software, andSCADA-like environments), turnkey instrument bundles and modular testing cells, consumables and replacement parts, calibration and validation services, software for data management and instrument integration, remote monitoring and predictive maintenance, and technical training and advisory services. Latest major company changes: forms strategic alliances with global distributors to expand regional service networks; completes a significant acquisition of a precision instrumentation firm to broaden sensor and automation capabilities; launches a new line of compact, high-sensitivity analytical instruments and accompanying cloud-based data analytics platform; undergoes organizational realignment to streamline global operations and establish regional hubs in Europe and North America; announces expansion plans into Southeast Asia with new manufacturing and service facilities. Additional context: operates within the instrumentation and analytical chemistry segments; targets pharmaceutical, biotech, chemical, materials science, and electronics customers; geographic footprint includes Japan, China, Korea, Taiwan, Europe, United States, and other regions via direct subsidiaries and partner networks; parent company relationships and any subsidiaries are disclosed in corporate filings and on the company website.